Chuffed on new launches, Eli Lilly unveils Street-beating 2020 sales forecast

Eli Lilly figures things are looking way up. With cost cuts and patent-cliff blows in the rearview mirror—and thanks to some outperforming new launches—the Indianapolis drugmaker rolled out better-than-expected revenue projections for 2020.